文献速递腹部泌尿生殖CT

CT测量的内脏脂肪性别差异与肿瘤代谢的协同作用有助于预测肾细胞癌患者的总生存期

Synergy of Sex Differences in Visceral Fat Measured with CT and Tumor Metabolism Helps Predict Overall Survival in Patients with Renal Cell Carcinoma.
PubMed 文献 · Radiology · 2018-03-20

该回顾性队列研究纳入222例透明细胞肾细胞癌患者,利用CT测量腹部内脏脂肪面积并归一化为相对内脏脂肪面积(rVFA),结合肿瘤糖酵解基因表达分析。女性rVFA>30.9%者死亡风险增加(HR 3.66,95%CI 1.64-8.19),男性无显著增加(HR 1.13,95%CI 0.58-2.18)。低rVFA且低糖酵解的女性患者总生存期极佳(P<0.001)。

要点

  • 女性rVFA>30.9%与死亡风险增加相关(HR 3.66),男性无此关联(HR 1.13)。
  • 低rVFA且低糖酵解的女性患者总生存期极佳(P<0.001)。
  • SETD2和BAP1突变在女性高糖酵解肿瘤中富集(P=0.036和0.001)。

核心结论

  • 内脏脂肪和肿瘤糖代谢的性别差异可能为透明细胞肾细胞癌患者提供新的风险分层系统。

研究设计与样本

  • 回顾性队列研究,纳入222例来自The Cancer Imaging Atlas的透明细胞肾细胞癌患者,使用CT测量皮下脂肪和内脏脂肪面积并归一化为rVFA和相对皮下脂肪面积,从The Cancer Genome Atlas获取39个糖酵解基因表达谱,分析关键突变与rVFA及糖酵解谱的关联。

关键影像表现/征象

  • CT上分割皮下脂肪和内脏脂肪面积,计算rVFA(内脏脂肪面积/总脂肪)和相对皮下脂肪面积。
  • 女性rVFA>30.9%者死亡风险增加(HR 3.66,95%CI 1.64-8.19),男性rVFA>30.9%者死亡风险无显著增加(HR 1.13,95%CI 0.58-2.18),组间P=0.028。

诊断标准与关键数值

  • 女性rVFA>30.9%时死亡风险增加,HR 3.66(95%CI 1.64-8.19);男性HR 1.13(95%CI 0.58-2.18),P=0.028。
  • 低rVFA且低糖酵解的女性患者总生存期极佳(P<0.001)。
  • SETD2和BAP1突变在女性高糖酵解肿瘤中富集(P=0.036和0.001)。

临床应用与阅片要点

  • 基于CT测量的rVFA和肿瘤糖酵解基因表达可能用于透明细胞肾细胞癌的性别特异性风险分层。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To determine if sex differences in abdominal visceral fat composition, measured by using computed tomography (CT), and tumor glucose metabolism, measured by gene expression, can help predict outcomes in patients with clear cell renal cell carcinoma (RCC). Materials and Methods This retrospective cohort study included 222 patients with clear cell RCC from The Cancer Imaging Atlas. By using CT, body fat was segmented into subcutaneous fat and visceral fat areas (VFAs) and normalized to total fat to obtain the relative VFA (rVFA) and relative subcutaneous fat area. Multivariate Cox proportional hazard regression models were performed to identify effects of rVFA on sex-specific survival. Expression profiles for 39 glycolytic genes in tumors from these patients were obtained from The Cancer Genome Atlas to determine sex differences in metabolism and compared with rVFA. Key mutations in clear cell RCC were analyzed for association with rVFA and tumor glycolytic profiles. Results Women with rVFA greater than 30.9% had an increased risk of death (hazard ratio, 3.66 [95% confidence interval: 1.64, 8.19]) for women vs 1.13 ([95% confidence interval: 0.58, 2.18] for men, P = .028). Glycolytic gene expression stratified both men and women, and the combination of low rVFA and low glycolysis identified 19 women with excellent overall survival (P < .001). SETD2 and BAP1 mutations were uniquely enriched in female tumors with high glycolysis (P = .036 and .001, respectively). No significant differences were identified in tumor mutations between patients with high and low rVFA. Conclusion Sex differences in visceral fat and tumor glucose metabolism may provide a new risk-stratification system for patients with clear cell RCC. © RSNA, 2018 Online supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Nguyen GK, Mellnick VM, Yim AK, et al. Synergy of Sex Differences in Visceral Fat Measured with CT and Tumor Metabolism Helps Predict Overall Survival in Patients with Renal Cell Carcinoma. Radiology. 2018. PMID: 29558292. doi:10.1148/radiol.2018171504

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。